Literature DB >> 8413967

Correlation of evoked potential and MRI findings in Wilson's disease.

L M Selwa1, C W Vanderzant, J A Brunberg, G J Brewer, I Drury, A Beydoun.   

Abstract

We recorded brainstem auditory evoked potentials (BAEPs) and somatosensory evoked potentials to median nerve stimulation (MSEPs) within 10 days of brain MRI in 20 patients with Wilson's disease (WD). MRI was abnormal in 90% of patients, demonstrating symmetric striatum and brainstem lesions with or without thalamic lesions. MSEPs were abnormal in 65% of patients, usually showing bilaterally prolonged N/P13-N20 latencies. BAEPs were abnormal in 40%, most often with bilateral prolongation of the III-V latency. The III-V and N/P13-N20 interpeak latencies correlated significantly with the severity of MRI lesions in the caudal pons, rostral pons, and caudal midbrain. Our results indicate that subclinical sensory dysfunction is common in WD, and that auditory and somatosensory pathways are most severely affected at the brainstem level. Both the localization and severity of evoked potential abnormalities correspond closely to the morphologic changes in the pons and caudal midbrain shown by MRI.

Entities:  

Mesh:

Year:  1993        PMID: 8413967     DOI: 10.1212/wnl.43.10.2059

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Wilson's disease: cranial MRI observations and clinical correlation.

Authors:  S Sinha; A B Taly; S Ravishankar; L K Prashanth; K S Venugopal; G R Arunodaya; M K Vasudev; H S Swamy
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

2.  [Electrophysiological impairment profile of patients with Wilson's disease].

Authors:  W Hermann; T Villmann; A Wagner
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

3.  Case report: concordant traumatic brainstem contusion delayed diagnosis in a young man with Wilson's disease.

Authors:  A Marcus; C Ammermann; M Klein; M H Schmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  1995-01       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.